Cartesian Therapeutics, Inc. (RNAC) Revenue by Year
Cartesian Therapeutics, Inc. generated $2.8M in revenue in fiscal year 2025. This represents a decrease of 92.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $1.5M in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Cartesian Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RNAC Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
RNAC Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Cartesian Therapeutics, Inc. financials
Frequently Asked Questions
What was Cartesian Therapeutics, Inc.'s revenue in fiscal year 2025?
Cartesian Therapeutics, Inc. generated $2.8M in revenue in fiscal year 2025.
How fast is Cartesian Therapeutics, Inc.'s revenue growing?
Cartesian Therapeutics, Inc. (RNAC) revenue fell by 92.8% year over year, from $38.9M to $2.8M in fiscal year 2025.
What is Cartesian Therapeutics, Inc.'s revenue over the last twelve months?
Cartesian Therapeutics, Inc. (RNAC) reported $1.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Cartesian Therapeutics, Inc.'s revenue changed over the years?
Across the 12 fiscal years this page covers, Cartesian Therapeutics, Inc. (RNAC) revenue went from $3.0M in fiscal year 2014 to $2.8M in fiscal year 2025.
What was Cartesian Therapeutics, Inc.'s revenue in the most recent quarter?
Cartesian Therapeutics, Inc. (RNAC) reported $0 in revenue in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Cartesian Therapeutics, Inc. (RNAC) reported on that line in every period on record.